ENTITY stringlengths 8 8 | DEFINITION stringlengths 3 8.47k ⌀ | ALIASES stringlengths 2 13.6k ⌀ | NAME stringlengths 2 1.98k |
|---|---|---|---|
C0003725 | Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed) | Arbovirus (navigational concept)|arbovirus|Arboviruses|Arthropod-borne Virus|Viruses, Arthropod-Borne|ARBOVIRUS|arboviruses|Arbovirus|Arthropod Borne Viruses|Virus, Arthropod-Borne|Arbovirus, NOS|Arthropod-Borne Viruses|Arthropod-Borne Virus | Arboviruses |
C0039258 | null | Tahyna virus (organism)|Tahyna virus | Tahyna virus |
C0318627 | null | Eyach virus|Eyach virus (organism) | Eyach virus |
C0012634 | A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. | Disease|Clinical disease or syndrome|Clinical disease or syndrome present, NOS|disorder|Disorders|Disease or syndrome present|disease|Diseases and Disorders|Clinical disease AND/OR syndrome present|condition|Diseases|Disease or syndrome present, NOS|Disorder, NOS|Other Disease|Clinical disease or syndrome, NOS|Disease ... | Disease |
C0042776 | Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. | Virus|Virus, NOS|Viruses, General|Virus (organism)|Vira|Viridae|VIRUSES|viruses|Viruses|viridae|virus|VIRUS | Virus |
C0999630 | null | Lepus capensis|Lepus capensis (organism)|Cape hare|Brown hare | Lepus capensis (organism) |
C0242210 | General term for proteins that have binding as a major function. | Ligand Binding Protein|Binding Protein|binding proteins|binding protein|Proteins, Binding|Protein, Binding|Binding protein (substance)|Binding protein | Binding Proteins |
C0053075 | null | null | beidellite |
C0053075 | null | null | beidellite |
C0242210 | General term for proteins that have binding as a major function. | Ligand Binding Protein|Binding Protein|binding proteins|binding protein|Proteins, Binding|Protein, Binding|Binding protein (substance)|Binding protein | Binding Proteins |
C0004611 | One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacte... | Unknown eubacteria|Bacterium sp.|unidentified bacterium|bacteria|eubacteria|Eubacteria|Bacteria|unidentified bacteria|unclassified bacterium|Superkingdom Bacteria|Bacteria bacterium|Bacterium, NOS|Domain Bacteria (organism)|Domain Bacteria|BACTERIA|Bacteria, Eubacteria|Bacteria, NOS|Bacterium|Unknown eubacterium|Bacter... | Bacteria |
C0031516 | Chemical substances, excreted by an organism into the environment, that elicit behavioral or physiological responses from other organisms of the same species. Perception of these chemical signals may be olfactory or by contact. | pheromones|Recognition odour|Recognition odor|Scent|scent|Pheromone|pheromone|scented|scents|Pheromones|Recognition odor (finding) | Pheromone |
C1167395 | Any organism in which another organism, especially a parasite or symbiont, spends part or all of its life cycle and from which it obtains nourishment and/or protection. [ISBN:0198506732] | hosts|host organism|host|Host | Host (organism) |
C0162318 | null | Farm Animal|Animals, Farm|Animal, Farm|Farm Animals|farm animal|animals farm|animal farm|farm animals | Farm Animals |
C0087111 | Procedures concerned with the remedial treatment or prevention of diseases. | treatment method|methods treatment|treatment|Therapeutics|TX|Therapeutic Method|therapeutic procedure|method treatment|Therapeutic procedure (procedure)|therapeutic method|Treatment|Therapy (regime/therapy)|therapy|Therapy, NOS|therapeutic intervention|Therapeutic Interventions|Procedure - therapeutic|Therapeutic Techn... | Therapeutic procedure |
C0059374 | A fluoroquinolone antibacterial and antimycoplasma agent that is used in veterinary practice. | Enrofloxacin|Enrofloxacin-containing product|Product containing enrofloxacin (medicinal product)|enrofloxacin|ENROFLOXACIN|3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-|1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolonecarboxylic acid|Endrofl... | enrofloxacin |
C0180153 | An object designed to conceal, enclose, cap, or protect something. | coverings|Cover Device|cover [device]|cover|covering|covers|Cover | Covers (device) |
C0004927 | The observable response of a man or animal to a situation. | behavioural response to stimulus|Behavior finding|conducts|Behaviour, NOS|Finding relating to behaviour|Behavioural finding|Behavioral|Behavior|Behavioral finding|Behavior, NOS|Conduct|Behaviour finding|Behaviors|Conation|behavior|conduct|conducting|behavioral response to stimulus|Behavior finding (finding)|behaviour|C... | Behavior |
C0015967 | An abnormal elevation of body temperature, usually as a result of a pathologic process. | Body temperature above reference range (finding)|Fever, unspecified|Elevated Core Body Temperature|raised temperature|TEMPERATURE ELEVATION|Fever|Fever (finding)|feverish|Has a temperature|hyperthermia|Increased body temperature|fever|Body temperature, increased|Febrile|BODY TEMPERATURE INCREASED|temperature elevation|... | Fever |
C0012931 | Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. | Recombinant deoxyribonucleic acid (substance)|dna recombinant|Recombinant DNA|recombinant dna|Recombinant deoxyribonucleic acid|rDNA|DNA Construct|Construct|DNA, Recombinant|recombinant DNA|Molecular Biology, Recombinant DNA|rdna | Recombinant DNA |
C0162699 | null | Tick-Borne Infection|Infections, Tick Borne|Tick Borne Infections|Infection, Tick-Borne|Infections, Tick-Borne | Tick-Borne Infections |
C0017677 | An idiopathic disorder of the tongue characterized by the loss of filiform papillae leaving reddened areas of circinate macules bound by a white band. The lesions heal, then others erupt. | lingua geographica|Lingual geographica|tongue geographic|Oral erythema migrans|Glossitis areata migrans|benign migratory glossitis|Glossitis, Benign Migratory|Geographical tongue|lingual geographica|Erythema Migrans, Lingual|TONGUE GEOGRAPHIC|GLOSSITIS, BENIGN MIGRATORY|Psoriasiform mucositis|Geographic Tongue|erythema... | Glossitis, Benign Migratory |
C1457887 | An indication that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain. | SYMPTOM|Symptoms|Symptom|SYMPTOMS|general manifestation of disorders|symptom|Symptom, NOS | Symptoms |
C0024198 | An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, ... | Lyme disease|Steere's disease|B. burgdorferi Infection|Infection due to Borrelia burgdorferi sensu lato|borrelia burgdorferi infection|lyme's disease|Lyme Disease|Lyme disease (disorder)|B. burgdorferi Infections|LYME DISEASE|Disease, Lyme|Infection by Borrelia burgdorferi|Borrelia burgdorferi Infection|Lyme borreliosi... | Lyme Disease |
C0011900 | The determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process. | diagnosis (DX)|Diagnoses|diagnose|diagnosing|Diagnostic|Diagnosed|Diagnosis (observable entity)|DIAGNOSIS|diagnoses|diagnosed|Dx|Diagnosis|diagnosis | Diagnosis |
C0079603 | null | immunofluorescence|Immunofluorescence|Immunofluorescence assay|Fluorescent immunoassay (procedure)|Immunofluorescence assay, NOS|immunofluorescence assay|assays immunofluorescence|Immunofluorescence technique|Fluorescent linked immunoassay|IF - Immunofluorescence|Fluorescent immunoassay (qualifier value)|IMF - Immunofl... | Immunofluorescence assay |
C0743841 | null | Febrile illness (fever)|Febrile disorder (disorder)|Disorder characterised by fever|Febrile syndrome|Febrile disorder|Febrile illness|febrile illness | Disorder characterized by fever |
C0638611 | null | 1H-Pyrrole-2-carboxylic acid, 4,5-dibromo-|4,5-dibromo-2-pyrrolic acid|DBPA | 4,5-dibromo-2-pyrrolic acid |
C0027895 | Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. | neuropeptide|Neuropeptide|neuropeptides|Neuropeptides | Neuropeptides |
C1504598 | null | null | Crosstalk - device related injury/complication |
C0024852 | An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA. | Marsupialia|ORDER MARSUPIALIA - MARSUPIALS OR POUCHED MAMMALS|Pouched mammal, NOS|marsupial|marsupials|Marsupials|Metatheria|Marsupial | Superorder Marsupalia (organism) |
C0024852 | An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA. | Marsupialia|ORDER MARSUPIALIA - MARSUPIALS OR POUCHED MAMMALS|Pouched mammal, NOS|marsupial|marsupials|Marsupials|Metatheria|Marsupial | Superorder Marsupalia (organism) |
C0024852 | An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA. | Marsupialia|ORDER MARSUPIALIA - MARSUPIALS OR POUCHED MAMMALS|Pouched mammal, NOS|marsupial|marsupials|Marsupials|Metatheria|Marsupial | Superorder Marsupalia (organism) |
C0024852 | An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA. | Marsupialia|ORDER MARSUPIALIA - MARSUPIALS OR POUCHED MAMMALS|Pouched mammal, NOS|marsupial|marsupials|Marsupials|Metatheria|Marsupial | Superorder Marsupalia (organism) |
C0024660 | Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young. | Mammal|Mammals|Mammalian|Mammalia|CLASS MAMMALIA - MAMMALS|Class Mammalia|mammals|Class Mammalia (organism)|Mammals, General|mammal | Mammals |
C0034850 | Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface. | endosome|Endosomes|Receptosome|Receptosomes|Endosome | Endosomes |
C0699040 | The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm] | cell bound|Cell Surface|Surface of cell|cell associated|External surface of plasma membrane|cell surface|External surface of plasmam membrane|Cell surface | Cell surface |
C1099354 | Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisens... | Short Interfering RNA|Interfering RNA, Small|interfering rnas small|small interfering rna|Interfering RNA, Short|Small interfering RNA|siRNA|RNA, Short Interfering|sirna|RNA, Small Interfering|Small Interfering RNA|small interfering RNA | RNA, Small Interfering |
C0817332 | null | Right calcaneus | Right calcaneus |
C0817332 | null | Right calcaneus | Right calcaneus |
C0817332 | null | Right calcaneus | Right calcaneus |
C0017262 | The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. | Gene expression|gene expression|expression gene|Gene Expression|Expression, Gene|Expressions, Gene|Expression|Expressed|Gene Expressions|Gene expression (finding) | Gene Expression |
C0042896 | Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the r... | Vitellogenins|vitellogenin|Vitellogenin | Vitellogenins |
C0042896 | Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the r... | Vitellogenins|vitellogenin|Vitellogenin | Vitellogenins |
C1533685 | Administration using positive pressure and a needle or other equipment to drive a substance into the body. | Administration of injection|INJECTIONS|Injection, NOS|Injection - action (qualifier value)|injection|Injection|Injections|Injection Administration|Injection - action|Injection (procedure) | Injection procedure |
C1334043 | A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These genes retain a similar sequence and function. | Homolog|Gene Homolog|Homologous|Homologous Gene|Homologous Association|Homologue|Homology | Homologous Gene |
C0751608 | A collection of DNA molecules that have been cloned in vectors. In the case of a cDNA library the DNA inserts are copies of RNAs that have been reverse-transcribed into DNA prior to cloning. | Libraries, cDNA|cDNA Libraries|Library|Library, cDNA|cDNA Library | cDNA Library |
C1281743 | A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual em... | Embryos, Preimplantation|Blastocyst structure|preimplantation embryos|Blastosphere|blastula stage|Embryo, Preimplantation|Preimplantation Embryos|blastosphere|Blastocyst structure (body structure)|Blastocysts|Preimplantation Embryo|blastula|Blastocyst|blastocysts|Blastula|blastocyst | Blastocyst structure |
C0162788 | A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. | In Situ Hybridizations|hybridization in situ|In Situ Hybridization|Hybridization, In Situ|Hybridizations, In Situ|IN SITU HYBRIDIZATION|in situ Hybridization|Genetics, in situ Hybridization|In-situ hybridization|hybridization situ|Hybridization in Situ|in situ hybridization|In situ hybridization|situ hybridization | In Situ Hybridization |
C0013935 | The entities of developing ANIMALS in early stages. | Embryonic|Pantemporal embryo|Embryo|embryo|Embryos|embryonic|Embryo, NOS|embryos | Embryo |
C0021358 | The posterior pair of the quadrigeminal bodies which contain centers for auditory function. | Posterior colliculus|Inferiors, Colliculus|Caudal Colliculus|Testes|Corpus quadrigeminum inferius|Colliculus Inferiors|Colliculus, Inferior|posterior colliculus|Posterior quadrigeminal body|Inferior Colliculi|Corpus bigeminum posterioris|Posterior corpus quadrigeminum|inferior colliculus|Colliculus inferior|Colliculus,... | Inferior Colliculus |
C0005539 | Application of principles and practices of engineering science to biomedical research and health care. | bioengineering/biomedical engineering|bioengineered|Engineering, Biomedical|bioengineering|biomedical engineering|Biomedical engineering|biomedical engineer|Biomedical Engineering | biomedical engineering field |
C0007634 | The fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary. | Cells|Cells set|cell|Cellula|Cell structure|Cell Type|Cell structure (cell structure)|Set of cells|cells|Cell Types|Cell|Normal cell|Normal Cell|Cellular structures|Cell, NOS|The Cell|{Cells}|THE CELL|Cellular structure|the cell|Cellular | Cells |
C0010834 | The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) | cytoplasma|cytoplasm|Cytoplasm|Cytoplasmic|Cytoplasms|Cytoplasma | Cytoplasm |
C0007610 | Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than... | Nucleus, Cell|Nucleus|NUCLEUS|Nucleus, NOS|Nucleic|cell nucleus|Nucleus of cell|Nuclei, Cell|cell nuclei|Nucleus (cell structure)|Cell nucleus|nucleus|Cell Nuclei|Cell nuclei|Cell Nucleus | Cell Nucleus |
C1185738 | Any cylindrical, vertical, upright structure. | Column|Column structure (qualifier value)|column|Column structure | Column (anatomic) |
C0031327 | Dynamic and kinetic mechanisms of exogenous chemical and DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolis... | pharmacokinetics|Drug Kinetics|mechanism of action|drug kinetics|PK|Pharmacokinetics|Kinetics, Drug | Drug Kinetics |
C0017973 | Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). | Glycosaminoglycan, NOS|mucopolysaccharides|Mucopolysaccharides|Glycosaminoglycan|Glycosaminoglycans|glycosaminoglycans|glycosaminoglycan|Mucopolysaccharide|Mucopolysaccharide, NOS|mucopolysaccharide|GAG|glycosaminoglycan (GAG)|Mucopolysaccharide (substance)|gag(glycosaminoglycan)|GAG - Glycosaminoglycan | Glycosaminoglycans |
C0015350 | A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. | Matrix, Extracellular|ecm|icm|intercellular matrix|Portion of extracellular matrix|Extracellular Matrix|Extracellular matrix|Intercellular matrix|Extracellular Matrices|Cell-Extracellular Matrix|proteinaceous extracellular matrix|ECM|ICM|Matrices, Extracellular|extracellular matrix | Extracellular Matrix |
C0017346 | DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen. | Gene, gag|gag Gene|GAg gene|Group-Specific Antigen Gene|GAG Gene|GAG|Genes, gag|GAg gene (observable entity)|gag Genes | GAG Gene |
C0013855 | An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current. | Electrophoresis measurement|Fractionation, Electrophoretic|electrophorese|Electrophoresis technique|ELECTROPHORESIS|Electrophoresis measurement, NOS|Zone electrophoresis measurement|Electrophoresis|Electrophoreses|electrophoresis|electrophoreses|Zone electrophoresis measurement, NOS|Electrophoresis measurement (procedu... | Electrophoresis |
C0014442 | Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. | enzyme|Enzymes|Enzyme (substance)|enzymes|Enzyme, NOS|Enzyme|Biocatalysts|ENZYMES | Enzymes |
C0220806 | A substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties. | chemical compounds|Chemical compound, NOS|Chemically|Chemical|Chemical product, NOS|Chemical, NOS|Chemicals|chemical compound|chemical|chemical substance|Chemical (substance)|chemicals | Chemicals |
C0011847 | null | Diabetes | Diabetes |
C1511790 | The activity of perceiving, discerning, discovering or identifying. | Detection|Detected | Detection |
C0004239 | Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter... | atrial flutter|Atrial flutter|FLUTTER ATRIAL|Atrial Flutters|Flutter, Atrial|flutter auricular|Flutter, Auricular|Atrial flutter (disorder)|Flutters, Atrial|Flutters, Auricular|Auricular Flutter|ATRIAL FLUTTER|Atrial Flutter|Auricular Flutters | Atrial Flutter |
C0039234 | Abnormally rapid heartbeats originating from one or more automatic foci (nonsinus pacemakers) in the HEART ATRIUM but away from the SINOATRIAL NODE. Unlike the reentry mechanism, automatic tachycardia speeds up and slows down gradually. The episode is characterized by a HEART RATE between 135 to less than 200 beats per... | Ectopic atrial tachycardia|Tachycardia, Ectopic Atrial|Atrial Tachycardia, Ectopic|Ectopic Tachycardia, Atrial|Ectopic Tachycardias, Atrial|Tachycardias, Atrial Ectopic|Atrial Ectopic Tachycardia|Atrial Tachycardias, Ectopic|Tachycardias, Ectopic Atrial|Tachycardia, Atrial Ectopic|Ectopic atrial tachycardia (disorder)|... | Tachycardia, Ectopic Atrial |
C0039235 | A rare form of supraventricular tachycardia caused by automatic, not reentrant, conduction initiated from sites at the atrioventricular junction, but not the ATRIOVENTRICULAR NODE. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication with a HEART RATE ranging from 140 to 250... | Ectopic Tachycardia, Junctional|Junctional Tachycardias, Ectopic|His bundle (junctional ectopic) tachycardia|Junctional Ectopic Tachycardias|Tachycardias, Ectopic Junctional|Junctional ectopic tachycardia|junctional tachycardia|Ectopic Junctional Tachycardias|His bundle tachycardia|junctional ectopic tachycardia|Juncti... | Tachycardia, Ectopic Junctional |
C0042514 | An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, ... | TACHYCARDIA VENTRICULAR|ventricular tachyarrhythmia|Ventricular Tachycardia|Ventricular tachycardia (Vtach)|ventricular tachycardia (V-tach)|Ventricular tachycardia (disorder)|ventricular tachycardia|TACHYCARDIA, VENTRICULAR|Ventricular tachycardia|vt|VT|VENTRICULAR TACHYARRHYTHMIA|Ventricular tachycardia, NOS|Ventricu... | Tachycardia, Ventricular |
C0025741 | An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | O methyl DOPA|methyldopa (levorotatory)|Methyldopa-containing product|AMD|alpha-Methyldopa|alpha-methyldopa|L-Tyrosine, 3-hydroxy-alpha-methyl-|L-alpha-Methyldopa|Methyldopa (substance)|Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine|(S)-(-)-alpha-Methyldopa|alpha-Methyl dopa|alpha-methyl-L-dopa|Alphamethyldopa|α-methyl-L... | methyldopa |
C0025741 | An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | O methyl DOPA|methyldopa (levorotatory)|Methyldopa-containing product|AMD|alpha-Methyldopa|alpha-methyldopa|L-Tyrosine, 3-hydroxy-alpha-methyl-|L-alpha-Methyldopa|Methyldopa (substance)|Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine|(S)-(-)-alpha-Methyldopa|alpha-Methyl dopa|alpha-methyl-L-dopa|Alphamethyldopa|α-methyl-L... | methyldopa |
C0029463 | A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) | Osteosarcoma, NOS|Osteosarcoma - disorder|Osteosarcoma Tumors|Osteosarcoma, no ICD-O subtype|OSTEOSARCOMA|OSTEOGENIC SARCOMA|Tumor, Osteosarcoma|Osteochondrosarcoma|Tumors, Osteosarcoma|bone sarcomas|osteochondrosarcoma|Osteosarcoma|osteosarcomas|osteoid sarcoma|Osteogenic Sarcoma|OSRC|bone sarcoma|OSTEOSARCOMA, MALIGN... | Osteosarcoma |
C0221002 | Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, n... | Primary hyperparathyroidism|HYPERPARATHYROIDISM PRIMARY|primary hyperparathyroidism|Hyperparathyroidism, primary|Hyperparathyroidisms, Primary|Primary Hyperparathyroidisms|Primary Hyperparathyroidism|HYPERPARATHYROIDISM, PRIMARY|Primary hyperparathyroidism (disorder) | Hyperparathyroidism, Primary |
C0006826 | A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Malignant cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of malignancy. Carcinoma is a malignancy that begins in the skin or in tissues that line or cover... | malignant neoplasms|malignant neoplasm|Malignant tumor|Malignant neoplasm without specification of site|NEOPLASM MALIGNANT|malignant tumour|malignant tumors|Unclassified tumor, malignant|malignant tumor|neoplasm/cancer|Tumor, malignant, NOS|Unclassified tumour, malignant|Malignant Tumor|Neoplasm, Malignant|Malignant Gr... | Malignant Neoplasms |
C0025741 | An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | O methyl DOPA|methyldopa (levorotatory)|Methyldopa-containing product|AMD|alpha-Methyldopa|alpha-methyldopa|L-Tyrosine, 3-hydroxy-alpha-methyl-|L-alpha-Methyldopa|Methyldopa (substance)|Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine|(S)-(-)-alpha-Methyldopa|alpha-Methyl dopa|alpha-methyl-L-dopa|Alphamethyldopa|α-methyl-L... | methyldopa |
C0025741 | An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. | O methyl DOPA|methyldopa (levorotatory)|Methyldopa-containing product|AMD|alpha-Methyldopa|alpha-methyldopa|L-Tyrosine, 3-hydroxy-alpha-methyl-|L-alpha-Methyldopa|Methyldopa (substance)|Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine|(S)-(-)-alpha-Methyldopa|alpha-Methyl dopa|alpha-methyl-L-dopa|Alphamethyldopa|α-methyl-L... | methyldopa |
C0699748 | The set of specific processes that generate the ability of an organism to induce an abnormal, generally detrimental state in another organism. [GOC:go_curators] | pathogeneses|Pathogenesis (attribute)|Pathogenesis|Pathogeneses|Pathogeneses (qualifier value)|pathogenesis | Pathogenesis |
C0029456 | Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. | Osteoporosis, unspecified|Bone rarefaction|Osteoporoses|osteoporosis|Osteoporosis (disorder)|OSTEOPOROSIS|Osteoporosis, NOS|Osteoporosis | Osteoporosis |
C0752046 | A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. | single nucleotide polymorphism|Single Nucleotide Polymorphisms|snp|Polymorphism, Single Base|single nucleotide polymorphisms|Nucleotide Polymorphism, Single|SNP|Polymorphisms, Single Nucleotide|single nucleotide polymorphism (SNP)|Nucleotide Polymorphisms, Single|SNPs|Polymorphism, Single Nucleotide|Single Nucleotide P... | Single Nucleotide Polymorphism |
C0017337 | A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. | Gene (substance)|Gene|genes|Genes|GENE|Gene, NOS|gene | Genes |
C1412100 | null | diamine oxidase|AOC1 gene|ABP|DIAMINE OXIDASE|amine oxidase copper containing 1|DAO1|AMILORIDE-BINDING PROTEIN 1|ABP1|AOC1|DAO | AOC1 gene |
C1412100 | null | diamine oxidase|AOC1 gene|ABP|DIAMINE OXIDASE|amine oxidase copper containing 1|DAO1|AMILORIDE-BINDING PROTEIN 1|ABP1|AOC1|DAO | AOC1 gene |
C0524722 | procedures performed on the gastrointestinal system or its parts, used in the treatment of disease, injuries, or deformities; includes excision of a portion of the gastrointestinal system. | Surgical Procedure, Gastrointestinal|Gastrointestinal Surgical Procedures|OR Gastrointestinal Therapeutic Procedure|Procedure, Gastrointestinal Surgical|gastrointestinal surgery|Surgical Procedures, Gastrointestinal|operative procedure on the gastrointestinal system|Procedures, Gastrointestinal Surgical|gastrointestina... | Gastrointestinal Surgical Procedure |
C0596119 | cell membrane found on the surface of vertebrate epithelial cells which faces the external lumen and may be involved in transport of substances across the cell. | apical membrane | apical membrane |
C0040549 | A poison made by certain bacteria, plants, or animals, including insects. | Toxin, NOS|Toxin|Toxins|Toxins, Biological|Toxin-containing product|toxin|Biological Toxins|Product containing toxin (product)|Toxin (substance)|toxins | Toxin |
C0596902 | Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS. | membrane transport protein|Transport Proteins, Membrane|transporter|transporters|membrane transport proteins|Membrane Transport Proteins|membrane transporter|Membrane Transporters|Transporters, Membrane | Membrane Transport Proteins |
C0001617 | Hormones synthesized in the cortex of the adrenal gland and consist of two subclasses, glucocorticoids (carbohydrate regulation) and mineralocorticoids (electrolyte regulation). | adrenal cortical hormone|Adrenal cortex hormone-containing product|Product containing adrenal cortex hormone (product)|Corticosteroids|adrenocorticosteroids|Adrenal cortical hormone-containing product|Adrenal cortical hormone, NOS|Adrenocorticosteroids|Product containing corticosteroid and corticosteroid derivative (pr... | Adrenal Cortex Hormones |
C0666743 | A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. | Infliximab-containing product|Infliximab|monoclonal antibody ca2|INFLIXIMAB|Product containing infliximab (medicinal product)|Infliximab (genetical recombination)|infliximab|cA2, Monoclonal Antibody|INFLIX|Monoclonal Antibody cA2|INF|cA2|inFLIXimab|MAb cA2|Infliximab (substance) | infliximab |
C1527392 | agents of both drug and biological origin often used in immunotherapy to stimulate, potentiate, or depress the immune response; also used to inhibit or enhance specific subclasses of immunocytes. | Immunomodulators|Immunomodulator|Immunomodulator-containing product|immunomodulator|Product containing immunomodulator (product)|Substance with immunomodulator mechanism of action|Substance with immunomodulator mechanism of action (substance) | Immunomodulators |
C0199176 | In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight... | Prophylaxis - intent|Prophylaxis, NOS|Preventive procedure (procedure)|Preventive treatment|Prevention|prevention|prophylaxis|PRYLX|PREVENTATIVE|preventive treatment|Prevention Measures|Prophylactic treatment|Prophylaxis - action|Preventive Intervention|Prophylactic treatment, NOS|Preventative treatment|Prophylaxis|Pro... | Prophylactic treatment |
C0086388 | The actions of prevention, treatment, and management of illness and the preservation of mental and physical well-being through the services offered by the medical and allied health professions. | Care, Health|Healthcare Activity|HealthCare|Health Care Activity|Health Care|health care|healthcare|Healthcare | Health Care |
C0030274 | A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive... | Exocrine and endocrine pancreas, NOS|Exocrine and endocrine pancreas|pancreas|Pancreas, NOS|Pancreatico-|Pancreas|pancreatic|Pancreo-|Pancreatic|PANCREAS|Pancreatic structure|Pancreatic structure (body structure)|Gastrointestinal Tract, Pancreas|pancreatico | Pancreas |
C0751973 | The protein complement of an organism coded for by its genome. | Proteome|proteome|Proteomes | Proteome |
C0025859 | A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. | 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol|METOPROLOL|metoprolol|Metoprolol|2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-|Product containing metoprolol (medicinal product)|DL-metoprolol|(RS)-Metoprolol|Metoprolol (substance)|Metoprolol-containing product | metoprolol |
C0070166 | A ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION. | Methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate|Clopidogrel|Clopidogrel-containing product|clopidogrel|CLOPIDOGREL|Clopidogrelum|Clopidogrel (substance)|Product containing clopidogrel (medicinal product) | clopidogrel |
C0679771 | The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors. | Harm Minimization|Reduction, Harm|Minimization, Harm|harm avoidance|harm reduction|harm minimization|HARM AVOIDANCE | Harm Reduction |
C0220908 | Evaluation strategies used to identify risk for conditions, diagnose disease early, and monitor change/progression over time. | screening|health screens|screen|screening health|Screening|Health Screening|Screening procedure (procedure)|Screening Procedures|Screening procedures|GENERAL DISEASE SCREENING PROCEDURES|health screenings|Screening procedure|screening procedures|health screening|Screenings|Screening procedure, NOS|health screen|Health ... | Screening procedure |
C0011854 | A chronic condition characterized by minimal or absent production of insulin by the pancreas. | Type 1 diabetes mellitus|Insulin-Dependent Diabetes Mellitus|Insulin Dependent Diabetes Mellitus 1|Diabetes mellitus type I|Diabetes Mellitus, Insulin-Dependent|Diabetes Mellitus, Sudden Onset|DIABETES MELLITUS, TYPE I|Diabetes mellitus type 1 (disorder)|IDDM|Juvenile-Onset Diabetes Mellitus|diabetes type 1|Insulin Dep... | Diabetes Mellitus, Insulin-Dependent |
C0233929 | A discharge of fluid from a living body | Emission, NOS|emission|Emission|Emission (finding)|emissions | Emission - Male genitalia finding |
C0677881 | Anticancer drugs that kill cells, especially cancer cells. | Cytotoxic Therapy|Cytotoxic Chemotherapy|Cytotoxic|cytotoxic chemotherapy | Cytotoxic Chemotherapy |
End of preview. Expand in Data Studio
Dataset Description
This dataset contains a list of biomedical concepts from the UMLS database.
Data Fields
Each concept has its corresponding CUI ID, Name, Aliases, and definition if available.
- Downloads last month
- 6